(19)
(11) EP 3 911 350 A1

(12)

(43) Date of publication:
24.11.2021 Bulletin 2021/47

(21) Application number: 20741089.5

(22) Date of filing: 14.01.2020
(51) International Patent Classification (IPC): 
A61K 38/00(2006.01)
A61K 38/35(2006.01)
C12N 15/09(2006.01)
A61K 38/22(2006.01)
C07K 14/695(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/35; A61K 47/38; A61K 9/0019
(86) International application number:
PCT/US2020/013543
(87) International publication number:
WO 2020/150262 (23.07.2020 Gazette 2020/30)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 17.01.2019 US 201916250711

(71) Applicant: Harrow IP, LLC
Nashville, TN 37205 (US)

(72) Inventors:
  • SAADEH, Dennis Elias
    Irvine, California 92618 (US)
  • BAUM, Mark L.
    San Diego, California 92130 (US)

(74) Representative: Simpson, Kirsty Mairi 
Venner Shipley LLP 200 Aldersgate
London EC1A 4HD
London EC1A 4HD (GB)

   


(54) ADRENOCORTICOTROPIC HORMONE-BASED PHARMACEUTICAL FORMULATIONS AND METHODS FOR FABRICATING AND USING THEREOF